Abstract
Iron deficiency anemia (IDA) is the most frequent nutritional disorder and can be found in 2–28% of the population in developing countries. It is one of the most frequent causes for consultation in clinical practice. In Spain, its prevalence is greater in women under 50 years of age (14.8%) and in those under 3 years of age (4.3–5.7%). In the evaluation of a patient with iron deficiency, the most important aspect is to identify and treat the underlying cause. Treatment options include oral compounds, which are a safe, economical, and effective option. Intravenous formulas are indicated for treatment of IDA when oral preparations are not adequate or when rapid supplementation is clinically necessary.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Medicine - Programa de Formación Médica Continuada acreditado
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
